AM

Aayush Malhotra

Active Director Director DIN 07062708
DIN 07062708 First appointment Feb 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2015
Shareholding value •••• Premium profile

About Aayush Malhotra

Data last updated:

Aayush Malhotra is a Director at Fervour Pharmaneutics Private Limited (since 2015). The company operates in Healthcare. Fervour Pharmaneutics Private Limited reported revenue of ₹27.6 Lakh (FY 2024).

DIN 07062708
Primary Designation Director
Industry Healthcare
First Appointment 17 Feb 2015
Oldest Company Age 11 yrs
Largest company Fervour Pharmaneutics Private Limited · ₹27.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Feb 20152015₹27.6 Lakh (FY 2024)Active

Board colleagues of Aayush Malhotra

Directorship timeline

Open interactive timeline →
Fervour Pharmaneutics Private Limited
Premium access

Shareholding and investment profile for Aayush Malhotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aayush Malhotra

Aayush Malhotra currently holds 1 directorship: Fervour Pharmaneutics Private Limited (Director, since 17 Feb 2015, revenue ₹27.6 Lakh (FY 2024)).

Aayush Malhotra was first appointed on 17 Feb 2015 as Director at Fervour Pharmaneutics Private Limited.

The current boards of Aayush Malhotra's companies include Aditi Malhotra (Fervour Pharmaneutics Private Limited), Shyam Singh (Fervour Pharmaneutics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available